Terms: = Thyroid cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Diagnosis
4 results:
1. nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma.
Wang Z; Li J; Liu Z; Yue L
Eur J Histochem; 2023 Mar; 67(2):. PubMed ID: 36951264
[TBL] [Abstract] [Full Text] [Related]
2. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-nrf2/HO-1 axis.
Li W; Huang G; Wei J; Cao H; Jiang G
Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
[TBL] [Abstract] [Full Text] [Related]
3. Novel Anaplastic thyroid cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
Maniakas A; Henderson YC; Hei H; Peng S; Chen Y; Jiang Y; Ji S; Cardenas M; Chiu Y; Bell D; Williams MD; Hofmann MC; Scherer SE; Wheeler DA; Busaidy NL; Dadu R; Wang JR; Cabanillas ME; Zafereo M; Johnson FM; Lai SY
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4652-e4665. PubMed ID: 34147031
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Novel Biomarker and Therapeutic Target Candidates for diagnosis and Treatment of Follicular Adenoma.
Lai X; Chen S
Cancer Genomics Proteomics; 2015; 12(6):271-81. PubMed ID: 26543076
[TBL] [Abstract] [Full Text] [Related]